Moisand Fitzgerald Tamayo, LLC Astrazeneca PLC Transaction History

Moisand Fitzgerald Tamayo, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$61.89 - $69.28 $3,280 - $3,671	-53 Reduced 13.28%	346 $23,000
Q3 2022 Oct 26, 2022	BUY	$53.02 - $135.75 $2,810 - $7,194	53 Added 15.32%	399 $22,000
Q1 2018 Apr 30, 2018	SELL	$32.97 - $36.63 $2,967 - $3,296	-90 Reduced 20.64%	346 $12,000
Q3 2017 Nov 03, 2017	BUY	$28.96 - $34.0 $12,626 - $14,824	436	436 $15,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.